News

Filter

Current filters:

Idenix Pharmaceuticals

1 to 9 of 10 results

Decision Resources Group analyst’s view on Merck’s decision to acquire Idenix

Decision Resources Group analyst’s view on Merck’s decision to acquire Idenix

12-06-2014

Given the huge potential, and interest in, the hepatitis treatment market, and US pharma giant Merck…

Anti-viralsIdenix PharmaceuticalsMerck & CoMergers & AcquisitionsPharmaceutical

Idenix Pharma files law suits against Gilead in Europe over sofosbuvir

Idenix Pharma files law suits against Gilead in Europe over sofosbuvir

14-03-2014

US drugmaker Idenix Pharmaceuticals says it has filed patent infringement law suits against biotech firm…

Anti-viralsBiotechnologyGilead SciencesIdenix PharmaceuticalsLegalNorthern EuropePatentssofosbuvirSovaldi

Idenix Pharma slumps as FDA calls for more data on IDX20963

24-06-2013

USA-based biotech firm Idenix Pharmaceuticals (Nasdaq: IDIX) saw its share price plunge as much as 31.8%…

Anti-viralsBiotechnologyIdenix PharmaceuticalsIDX20963North AmericaRegulation

Idenix plunges as FDA puts clinical hold on hepatitis C drug candidate

17-08-2012

US biotech firm Idenix Pharmaceuticals (Nasdaq: IDIX) saw its shares tank 29% to $5.91 in morning trading…

Anti-viralsBiotechnologyIdenix PharmaceuticalsIDX184North AmericaPharmaceuticalRegulationResearch

Novartis restructures deal with Idenix Pharmaceuticals

01-08-2012

USA-based Idenix Pharmaceuticals (Nasdaq: IDIX) says that Swiss drug major Novartis (NOVN: VX) has restructured…

Anti-viralsIdenix PharmaceuticalsLicensingNovartisPharmaceuticaltelbivudine

News of clinical hold on AIDS drug sees Idenix Pharma shares plunge 25%

10-02-2011

US biotech firm Idenix Pharmaceuticals (Nasdaq: IDIX) saw its shares plunge 25% to $3 in extended trading…

Anti-viralsBiotechnologyGlaxoSmithKlineIdenix PharmaceuticalsPharmaceuticalRegulationResearchViiV Healthcare

1 to 9 of 10 results

COMPANY SPOTLIGHT

Menarini

Back to top